Fri, Feb-06-15, 13:00
|
|
Senior Member
Posts: 1,449
|
|
Plan: Atkins, Newcastle
Stats: 260/221.8/165
BF:Highest weight 260
Progress: 40%
Location: Northern California
|
|
I’m really bugged by this thing where long term low carbers/paleo eaters wind up with higher than ideal fasting BG numbers. Everything I’ve read tells me that this is a good, healthy way to eat, and yet there’s those damned BG numbers. Why won’t my FBG go down into the 80s?
Of course, it could be that the researchers are all wrong about the effects of low carb eating, and maybe we are as well, but what are my choices? If I continue to eat low carb, I will have to just ignore those FBG numbers, unless they get truly crazy, which may indicate I need to use metformin (I certainly don’t want to use exogenous insulin. I know one thing for sure, if I eat more carbs, my FBG gets even worse, and my post-prandial readings go nuts. That just can’t be a better choice than what I’m doing now.
For now, I’ve decided that what I’m doing is the right way to eat, and there is something going on with the fasting glucose readings that nobody completely understands at this point. Which brings me to this paper, which indicates that maybe, just maybe, this matter of IR caused higher FBG can be a good thing, even a life extending thing. The authors suspect that the IR and higher BG numbers which are caused by severe CR diets and mimicked by intake of rapamycin, are a natural result of reducing the mTOR nutrient signalling pathway. Could it be that long term low carb eating has the same effect?
Quote:
Once again on rapamycin-induced insulin resistance and longevity: despite of or owing to
Mikhail V. Blagosklonny
Author information ► Article notes ► Copyright and License information ►
This article has been cited by other articles in PMC.
http://www.ncbi.nlm.nih.gov/pubmed/22683661
Some extracts:
Abstract
Calorie restriction (CR), which deactivates the nutrient-sensing mTOR pathway, slows down aging and prevents age-related diseases such as type II diabetes. Compared with CR, rapamycin more efficiently inhibits mTOR. Noteworthy, severe CR and starvation cause a reversible condition known as “starvation diabetes.” As was already discussed, chronic administration of rapamycin can cause a similar condition in some animal models. A recent paper published in Science reported that chronic treatment with rapamycin causes a diabetes-like condition in mice by indirectly inhibiting mTOR complex 2. Here I introduce the notion of benevolent diabetes and discuss whether starvation-like effects of chronic high dose treatment with rapamycin are an obstacle for its use as an anti-aging drug.
---------------------------------------------------------------------------
Starvation diabetes-like condition with low mTOR activity
If you read the Abstract, you might wonder whether rapamycin extends lifespan despite or because of “starvation-like diabetes”. As described by Lamming et al [1, 2] extending several previous observations [3-6], chronic administration of high doses of rapamycin causes insulin resistance in mice. Yet, at similar doses, rapamycin prolongs life span in mice [7, 8]. Moreover, in several studies, rapamycin prevented complications of diabetes such as nephropathy [9-14]. Also, theoretical considerations indicate rapamycin for retinopathy [15], which was recently confirmed in an animal model [16]. Rapamycin prevents atherosclerosis in rodents [17-20] and coronary re-stenosis in humans [21, 22]. In contrast, diabetes promotes nephropathy, retinopathy, atherosclerosis and coronary disease. How could this be reconciled? mTOR is a part of a nutrient-sensing pathway [23-27]. Nutrients and insulin activate mTOR. Rapamycin, which inhibits mTOR, is a “starvation-mimetic”, making the organism “think” that food is in a short supply. The most starvation-sensitive organ is the brain. The brain consumes only glucose and ketones. Therefore, to feed the brain during starvation, the liver produces glucose from amino acids (gluconeogenesis) and ketones from fatty acids (ketogenesis). Since insulin blocks both processes, the liver needs to become resistant to insulin. Also secretion of insulin by beta-cells is decreased. And adipocytes release fatty acids (lipolysis) to fuel ketogenesis by the liver. Thus, there are five noticeable metabolic alterations of starvation: gluconeogenesis, ketogenesis, insulin resistance, low insulin levels and increased lipolysis. This metabolic switch is known as starvation diabetes, a reversible condition, described 160 years ago (see for references [28]). Starvation diabetes could be explained by deactivation of mTOR, which otherwise is activated by nutrients. In theory, rapamycin can cause similar symptoms in the presence of nutrients.
--------------------------------------------------------------------------------
The two opposite conditions?
Type II diabetes and starvation diabetes seem to be the two opposite conditions: the first is associated with activation of nutrient-sensing pathways, whereas the second is associated with deactivation of nutrient sensing pathways such as mTOR. Type II diabetes is dangerous by its complications such as retinopathy, neuropathy and accelerated atherosclerosis and cancer. Long-term effects of prolonged “starvation diabetes” is not known of course: it could not last for a long time, otherwise an animal (or human) would die from starvation. Or would not? An outstanding study by Fontana et al provides some answers [55]. Among individuals who had been practicing sever CR for an average of 7 years, 40% of CR individuals exhibited “diabetic-like” glucose intolerance, despite low levels of fasting glucose, insulin and inflammatory cytokines as well as excellent other metabolic profiles. In comparison with the rest CR individuals, they had lower BMI, leptin, circulating IGF-I, testosterone, and high levels of adiponectin, which are key adoptations to CR in rodents, suggesting severe CR [55]. The authors speculated that the “insulin resistance” in this severe CR group might have the effect of slowing aging, also based on the finding that a number of insulin-resistant strains of mice are long-lived [55]. The same conclusion could be reached from the mTOR perspective (Appendix 1).
|
|
|